ATE259221T1 - Magensaftresistente tablette für nahrung, diät und therapie - Google Patents

Magensaftresistente tablette für nahrung, diät und therapie

Info

Publication number
ATE259221T1
ATE259221T1 AT00974794T AT00974794T ATE259221T1 AT E259221 T1 ATE259221 T1 AT E259221T1 AT 00974794 T AT00974794 T AT 00974794T AT 00974794 T AT00974794 T AT 00974794T AT E259221 T1 ATE259221 T1 AT E259221T1
Authority
AT
Austria
Prior art keywords
formulation
diet
therapy
food
juice resistant
Prior art date
Application number
AT00974794T
Other languages
English (en)
Inventor
Alessandro Seneci
Pia Alberico
Original Assignee
Truffini & Regge Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Truffini & Regge Farmaceutici filed Critical Truffini & Regge Farmaceutici
Application granted granted Critical
Publication of ATE259221T1 publication Critical patent/ATE259221T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT00974794T 1999-10-21 2000-10-20 Magensaftresistente tablette für nahrung, diät und therapie ATE259221T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT1999MI002206A IT1315252B1 (it) 1999-10-21 1999-10-21 Compresse gastroresistenti ad uso alimentare o dietetico ottenutemediante grassi miscelati alla massa
PCT/IT2000/000424 WO2001028526A2 (en) 1999-10-21 2000-10-20 Gastroresistant tablets for alimentary, dietetic and therapeutic use

Publications (1)

Publication Number Publication Date
ATE259221T1 true ATE259221T1 (de) 2004-02-15

Family

ID=11383827

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00974794T ATE259221T1 (de) 1999-10-21 2000-10-20 Magensaftresistente tablette für nahrung, diät und therapie

Country Status (7)

Country Link
EP (1) EP1225876B1 (de)
AT (1) ATE259221T1 (de)
AU (1) AU1300001A (de)
DE (1) DE60008276T2 (de)
ES (1) ES2215079T3 (de)
IT (1) IT1315252B1 (de)
WO (1) WO2001028526A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20300304U1 (de) * 2003-01-09 2003-04-24 Mann Gerhard Chem Pharm Fab Ocuvite Zink
US8697138B2 (en) 2007-03-28 2014-04-15 Aker Biomarine As Methods of using krill oil to treat risk factors for cardiovascular, metabolic, and inflammatory disorders
ES2415684T3 (es) 2007-03-28 2013-07-26 Aker Biomarine As Composiciones de aceite de kril biológicamente eficaces
EP2022503B1 (de) * 2007-08-07 2011-10-19 Symrise AG Verkapselte Vacciniumextrakte mit ausgewogener Magen-Darm-Freisetzung
US8372812B2 (en) * 2009-02-26 2013-02-12 Aker Biomarine Asa Phospholipid and protein tablets
AU2014203179C1 (en) 2013-06-14 2017-05-04 Aker Biomarine Antarctic As Lipid extraction processes
GB201400431D0 (en) 2014-01-10 2014-02-26 Aker Biomarine As Phospholipid compositions and their preparation
SI3197556T1 (sl) 2014-09-22 2024-03-29 Ntc S.R.L Sestavek za preprečevanje in/ali zdravljenje alergijskih simptomov
RU2718983C2 (ru) 2015-02-11 2020-04-15 Акер Биомарин Антарктик Ас Композиции липидов
EP3256003B1 (de) 2015-02-11 2022-11-09 Aker Biomarine Antarctic AS Lipidextraktionsverfahren
ITUB20153066A1 (it) 2015-08-11 2017-02-11 Graal S R L Composizione alimentare e/o nutraceutica contenente pea
WO2018135612A1 (ja) * 2017-01-20 2018-07-26 株式会社カネカ グルタチオンを含む粒状肥料
EP3731818A1 (de) 2017-12-27 2020-11-04 Graal S.r.l. Verfahren zur herstellung von festen formulierungen mit verzögerter freisetzung
CN112618500B (zh) * 2020-12-24 2022-12-09 广州汉光药业股份有限公司 叶酸制剂及其制备方法
WO2024095081A1 (en) * 2022-10-31 2024-05-10 S.I.I.T. s.r.l. - SERVIZIO INTERNAZIONALE IMBALLAGGI TERMOSALDANTI Chewable composition comprising a gummy matrix and comprising melatonin, sodium alginate, and calcium lactate

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374082A (en) * 1981-08-18 1983-02-15 Richard Hochschild Method for making a pharmaceutical and/or nutritional dosage form
DE3914622A1 (de) * 1989-05-03 1990-11-08 Fiegert Seibt Edda Dr Rer Nat Arzneimittel auf basis lipoider grundlagen
WO1995005808A1 (en) * 1993-08-24 1995-03-02 Abbott Laboratories Oil-based tableting method
GB2305604B (en) * 1995-09-29 1999-06-23 Quest Vitamins Ltd Carrier base material
GB9702799D0 (en) * 1997-02-12 1997-04-02 Scherer Corp R P Process for preparing solid pharmaceutical dosage forms

Also Published As

Publication number Publication date
EP1225876B1 (de) 2004-02-11
ITMI992206A0 (it) 1999-10-21
DE60008276T2 (de) 2004-12-16
ITMI992206A1 (it) 2001-04-21
AU1300001A (en) 2001-04-30
DE60008276D1 (de) 2004-03-18
EP1225876A2 (de) 2002-07-31
IT1315252B1 (it) 2003-02-03
WO2001028526A2 (en) 2001-04-26
WO2001028526A3 (en) 2001-12-06
ES2215079T3 (es) 2004-10-01

Similar Documents

Publication Publication Date Title
ATE259221T1 (de) Magensaftresistente tablette für nahrung, diät und therapie
US20020150607A1 (en) Food bars containing nutritional supplements
CA2559755C (en) Dietary supplement and method for treating digestive system-related disorders
JPWO2005023021A1 (ja) ダイエット食品
KR20070111478A (ko) 영양 보충을 위한 조성물과 방법
CN108450938A (zh) 一种减脂代餐粉及其制备方法
WO2020009111A1 (ja) 脂肪蓄積抑制用組成物
Morris et al. Unproven diet therapies in the treatment of the chronic fatigue syndrome
JPH08503964A (ja) 食餌療法の低コレステロール血組成物
US20020018787A1 (en) Methods and compositions for modulating immune response and for the treatment of inflammatory disease
CN107624068B (zh) 包含肉桂醛和锌的组合物及此类组合物的使用方法
EP1393738A4 (de) Arzneimittel gegen diabetes
Miller Unresolved Feeding and Nutrition Problems of the Chronically III Aged
Spies Some recent advances in nutrition
JP2006160697A (ja) 睡眠健康改善剤
Winter Vitamin E: Your protection against exercise fatigue, weakened immunity, heart disease, cancer, aging, diabetic damage, environmental toxins
Heijerman et al. Ranitidine compared with the dimethylprostaglandin E2 analogue enprostil as adjunct to pancreatic enzyme replacement in adult cystic fibrosis
JP7294147B2 (ja) 侵害受容性疼痛の予防又は改善用組成物
Cowgill Vitamin B1 in Relation to the Clinic
Karvonen et al. Safety and possible anti-diarrhoeal effect of the probiotic Lactobacillus reuteri after oral administration to neonates
WO2000054792A1 (fr) Medicaments, aliments, boissons et aliments pour animaux contenant un composant de cacao
Blandford et al. Muscle contractures associated with glucocorticoid deficiency.
Hegedus et al. IIPERSPECTIVES IN PRACTICEII
JP2004041006A (ja) 液状栄養組成物
RU2154474C2 (ru) Способ лечения алиментарной дистрофии

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties